好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2006 Annual Meeting | Headaches in Adults I

Sunday 04/02/06
09:00 AM - 12:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Todd D. Rozen, MD, FAAN
Upon Completion:
Participants should have a better understanding of the current concepts of migraine pathogenesis; be familiar with current acute and preventive treatment strategies for migraine; develop a better understanding of the concept of analgesic overuse headache and its treatment; and have a better understanding of the secondary causes of head and face pain.
No CME available
Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
09:00 AM - 09:45 AM Update on Migraine Pathogenesis
Peter Goadsby, MD, PhD, FRS
09:45 AM - 10:30 AM The ABCs of Migraine Treatment
Stephen D. Silberstein, MD, FAAN
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Analgesic Overuse Headache: History, Pathogenesis, and Treatment
Joel R. Saper, MD, FAAN
11:30 AM - 12:15 PM Secondary Causes of Head and Face Pain
David J. Capobianco, MD, FAAN
12:15 PM - 12:45 PM Discussion
Faculty Disclosures
Joel R. Saper, MD, FAAN No disclosure on file
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities.
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received publishing royalties from a publication relating to health care.
David J. Capobianco, MD, FAAN No disclosure on file
Todd D. Rozen, MD, FAAN No disclosure on file